跳至主要内容
临床试验/EUCTR2013-000092-33-AT
EUCTR2013-000092-33-AT进行中(未招募)不适用

Enhanced efficacy of photodynamic therapy in combination with 5% imiquimod -a randomised, prospective, observer-blinded study in patients with non melanoma skin cancer - PDT vs. PDT and 5% Imiquimod in patients with NMSC

Medizinische Universität Wien, Univ.Klinik.f.Dermatologie0 个研究点开始时间: 2013年9月19日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with clinically confirmed non melanoma skin cancer elswhere on the body
  • Age 18 years or older
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 88

排除标准

  • known allergy to imiquimod and aminolevulinic acid
  • patients who are participating in another study
  • patients with instable organ function
  • pregnant or lactating women
  • patients unable to stick to the study protocoll
  • patients with severe compromised general state
  • Patients with porphyria or taking photosensitizing drugs

研究者

发起方
Medizinische Universität Wien, Univ.Klinik.f.Dermatologie

相似试验